Cargando…

Response to ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14: 51–69)

Detalles Bibliográficos
Autores principales: Watkins, Claire, Rukazenkov, Yuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373487/
https://www.ncbi.nlm.nih.gov/pubmed/21029366
http://dx.doi.org/10.1111/j.1582-4934.2010.01188.x
_version_ 1782363349350088704
author Watkins, Claire
Rukazenkov, Yuri
author_facet Watkins, Claire
Rukazenkov, Yuri
author_sort Watkins, Claire
collection PubMed
description
format Online
Article
Text
id pubmed-4373487
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-43734872015-04-20 Response to ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14: 51–69) Watkins, Claire Rukazenkov, Yuri J Cell Mol Med Letter to the Editor Blackwell Publishing Ltd 2010-11 2010-11-29 /pmc/articles/PMC4373487/ /pubmed/21029366 http://dx.doi.org/10.1111/j.1582-4934.2010.01188.x Text en © 2010 The Authors Journal compilation © 2010 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
spellingShingle Letter to the Editor
Watkins, Claire
Rukazenkov, Yuri
Response to ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14: 51–69)
title Response to ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14: 51–69)
title_full Response to ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14: 51–69)
title_fullStr Response to ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14: 51–69)
title_full_unstemmed Response to ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14: 51–69)
title_short Response to ‘Clinical outcomes in NSCLC patients with EGFR mutations: pooled analysis’ (Paz-Ares et al., J Cell Mol Med. 2010; 14: 51–69)
title_sort response to ‘clinical outcomes in nsclc patients with egfr mutations: pooled analysis’ (paz-ares et al., j cell mol med. 2010; 14: 51–69)
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373487/
https://www.ncbi.nlm.nih.gov/pubmed/21029366
http://dx.doi.org/10.1111/j.1582-4934.2010.01188.x
work_keys_str_mv AT watkinsclaire responsetoclinicaloutcomesinnsclcpatientswithegfrmutationspooledanalysispazaresetaljcellmolmed2010145169
AT rukazenkovyuri responsetoclinicaloutcomesinnsclcpatientswithegfrmutationspooledanalysispazaresetaljcellmolmed2010145169